静脉注射氨甲环酸对全肩关节置换术失血量及术后早期疼痛的影响
一项随机安慰剂对照试验纳入54例接受单侧初次全肩关节置换术的患者,比较静脉给予氨甲环酸1000mg与生理盐水对围手术期失血、输血率及早期临床结局的影响。结果显示氨甲环酸组引流血量、计算总失血量、术后早期疼痛评分及血肿发生率均显著低于安慰剂组,两组均无需输血,未发生与氨甲环酸相关的不良事件。
要点
- 静脉氨甲环酸组围手术期引流量平均50ml,安慰剂组170ml(p=0.001)。
- 氨甲环酸组计算总失血量平均871.0ml,安慰剂组1248.2ml(p=0.009)。
- 氨甲环酸组血肿发生率25.9%(n=6),安慰剂组59.3%(n=16)(p=0.027)。
核心结论
- 静脉给予氨甲环酸成功减少了全肩关节置换术的围手术期引流量、估计总失血量、术后早期疼痛及血肿形成。
研究设计与样本
- 随机安慰剂对照试验,纳入54例接受单侧初次无柄解剖型或有柄反式全肩关节置换术的患者。
主要发现
- 围手术期引流量安慰剂组170ml vs 氨甲环酸组50ml(p=0.001),氨甲环酸组较安慰剂组降低。
- 计算总失血量安慰剂组1248.2ml vs 氨甲环酸组871.0ml(p=0.009),氨甲环酸组较安慰剂组降低。
- 研究期间两组均无需输血。
- 疼痛视觉模拟评分从术前7分显著降至术后早期1.7分(p<0.001)。
- 术后平均疼痛评分安慰剂组2.0分 vs 氨甲环酸组1.3分(p=0.05)。
关键数值与推荐
- 氨甲环酸组:皮肤切开前及伤口关闭时静脉给予100ml生理盐水加1000mg氨甲环酸。
- 安慰剂组:皮肤切开前及伤口关闭时静脉给予100ml生理盐水。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The purpose of the present study was to evaluate the impact of intravenous tranexamic acid on the reduction of blood loss, transfusion rate, and early post-operative clinical outcome in total shoulder arthroplasty. PATIENTS AND METHODS: A randomised, placebo-controlled trial which included 54 patients undergoing unilateral primary stemless anatomical or stemmed reverse total shoulder arthroplasty was undertaken. Patients received either 100 ml saline (placebo, n = 27), or 100 ml saline together with 1000 mg of tranexamic acid (TXA, n = 27) intravenously prior to skin incision and during wound closure. Peri-operative blood loss via an intra-articular drain was recorded and total blood loss was calculated. The post-operative transfusion rate was documented. Assessment of early clinical parameters included the visual analogue scale for pain (VAS), documentation of haematoma formation and adverse events. RESULTS: Mean peri-operative blood drainage (placebo: 170 ml versus TXA: 50 ml, p = 0.001) and calculated mean total blood loss (placebo: 1248.2 ml versus TXA: 871.0 ml, p = 0.009) were significantly lower in the TXA group. No transfusions were necessary during the study period in either group. Mean VAS for pain significantly decreased from pre-operative (VAS 7) to the early post-operative period (VAS 1.7, p < 0.001). Significant differences regarding mean post-operative pain between placebo (VAS 2.0) and TXA (VAS 1.3) were detected (p = 0.05). The occurrence of haematomas was significantly more frequent in the placebo (59.3%, n = 16) than in the TXA group (25.9%, n = 6, p = 0.027). Whereas only mild haematomas developed in the TXA group, in the placebo group a total of 22.2% (n = 6) developed either moderate or severe haematomas. No adverse events associated with administration of TXA occurred. CONCLUSION: Intravenous administration of TXA successfully reduced mean peri-operative blood drainage, total estimated blood loss, pain during the first post-operative days, and haematoma formation in total shoulder arthroplasty. Cite this article: Bone Joint J 2017;99-B:1073-9.
引用
- Pauzenberger L, Domej MA, Heuberer PR, et al. The effect of intravenous tranexamic acid on blood loss and early post-operative pain in total shoulder arthroplasty. Bone Joint J. 2017. PMID: 28768785. doi:10.1302/0301-620X.99B8.BJJ-2016-1205.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。